Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Skin News
Wednesday, September 30, 2009 FDA Finally OKs Stelara for Psoriasis
The FDA has approved Centocor's Stelara (ustekinumab) for moderate to severe psoriasis...
Thursday, September 24, 2009 Rituximab Improves SSc Lung Function
A small pilot study has established proof-of-principle that rituximab improves lung function in scleroderma...
Wednesday, August 19, 2009 Echo Urged to Rule Out PAH in High-Risk Lupus
Echocardiogram screening may be useful in identifying pulmonary arterial hypertension in high risk lupus patients...
Thursday, August 13, 2009 Docs Miss Details in Psoriasis Visits
In-office communication between psoriasis patients and clinicians needs improvement...
Wednesday, August 05, 2009 Psoriasis: Not Just Skin Deep
Mark G. Lebwohl, MD says psoriasis affects the heart and other vital organs, and treatment with TNF-blockers may reduce the risk of these comorbidities...
Wednesday, August 05, 2009 Lupus with Leucopenia, Anemia Signals Risk of Leukemia
Lupus patients with persistent leucopenia or anemia may be at risk for myeloid leukemia...
Monday, April 27, 2009 Two Big Steps for Lupus Nephritis Research
Genes that encode CXCR4/CXCL12 and kallikrein help determine whether lupus patients will develop kidney damage...
Thursday, April 09, 2009 Genentech Pulls Psoriasis Drug Raptiva Due to PML
Roche's Genentech unit will pull the psoriasis drug Raptiva® (efalizumab) due to PML risk...
Thursday, April 09, 2009 Rituximab May Help Some Severe Lupus Nephritis Cases
Rituximab treatment that achieves early B-cell depletion in cases of severe lupus nephritis can induced complete or partial remission in 60% of patients...
Tuesday, March 17, 2009 New Laser for Psoriasis Aims to Cut Treatment
The excimer laser, best known for its use in eye surgery, is providing some patients with relief from their psoriasis...